Clinical Trial Update: Study of Vimseltinib for Tenosynovial Giant Cell Tumor [Phase 3]

View source ↗

Summary

Phase 3 study of vimseltinib for Tenosynovial Giant Cell Tumor has posted results; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tenosynovial Giant Cell Tumor

Drugs mentioned

• Vimseltinib (Vimseltinib)

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-24